{"alanine aminotransferase increased": 4.79, "ascites": 25.59, "aspartate aminotransferase increased": 5.07, "blood bilirubin increased": 16.37, "cytopenia": 22.08, "death": 2.01, "febrile neutropenia": 11.58, "general physical health deterioration": 3.7, "graft versus host disease": 48.92, "hepatic function abnormal": 3.21, "liver disorder": 7.27, "multiple organ dysfunction syndrome": 9.17, "myelosuppression": 7.46, "neoplasm progression": 92.48, "neoplasm recurrence": 168.48, "neutropenia": 4.03, "neutrophil count decreased": 17.32, "off label use": 2.01, "pancytopenia": 6.37, "platelet count decreased": 16.49, "product use issue": 4.3, "sepsis": 3.85, "thrombocytopenia": 7.19, "tumour lysis syndrome": 35.41, "venoocclusive disease": 523.03, "venoocclusive liver disease": 1035.61, "weight increased": 2.25, "white blood cell count decreased": 9.78}